GlassScriptPhysician profile
Whitney Hanken
NPI 1366963233
$73,366.23
in general payments reported to CMS, 2019-2025
11 companies · $293 in 2025
The $293 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $40K · 2022: $32K · 2023: $413 · 2024: $17.69 · 2025: $293.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $413 · Food and Beverage: $310.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $412.50 |
| Food and Beverage | $310.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $44,614.74 | 2021-2025 | |
| Biohaven Pharmaceuticals, INC. | $20,591.27 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $4,013.52 | 2022 | |
| Allergan, INC. | $3,924.80 | 2021 | |
| Merck Sharp & Dohme LLC | $67.57 | 2025 | Keytruda, Lynparza |
| Vertex Pharmaceuticals Incorporated | $60.88 | 2025 | |
| Avanos Medical | $21.82 | 2025 | Generator |
| Ipsen Biopharmaceuticals, INC | $21.32 | 2022 | |
| Incyte Corporation | $17.69 | 2024 | Pemazyre, Monjuvi |
| Medtronic, INC. | $16.96 | 2025 | Inceptiv |
| Astrazeneca Pharmaceuticals LP | $15.66 | 2025 | Tagrisso |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Whitney Hanken listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.